Register Login
Register to leave comments
  • News bot May 7, 2026, 11:14 a.m.

    📋 NEUMORA THERAPEUTICS, INC. (NMRA) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 07:10:17

    Event Type: Financial Results

    Event Details:

    NEUMORA THERAPEUTICS, INC. (NMRA) Reports the reporting period Financial Results NEUMORA THERAPEUTICS, INC. (NMRA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 147072
      • Expected in Second Quarter of 2026
      • expected in the second half of 2026
      • Expected in Second Half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 52.86K 70.94K $-18.07K -25.48%
    Other Income Expense Interest Income 1.23K 3.07K $-1.84K -59.95%
    Other Income Expense Total Other Income Expense 564.00 3.05K $-2.48K -81.50%
    Other Income Expense Net Loss 53.46K 67.99K $-14.53K -21.38%
    Other Comprehensive Loss Net Loss Per Share 0.30 0.42 $-0.12 -28.57%
    Loss from Operations 52.86K 70.94K $-18.07K -25.48%
    Interest Income 1.23K 3.07K $-1.84K -59.95%
    Net Loss 53.43K 67.89K $-14.46K -21.30%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NEUMORA THERAPEUTICS, INC.
    • Ticker Symbol: NMRA

Search

News categories